drugset / Trial / NCT02958696
Relative Bioavailability of HTL0018318 Oral Aqueous Solution Versus Capsules
RandomizedCrossoverOpen-labelTreatment
Summary
HTL0018318 is a selective muscarinc M1 agonist. This study is a phase I, open label, randomised, crossover, single dose, trial in healthy volunteers to compare the relative bioavailability of HTL0018318 when given by oral aqueous solution and in capsule formulation.
Timeline
- Start
- 2016-10
- Primary completion
- 2017-01
- Completion
- 2017-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | HTL0018318 | Unknown | — | Oral |
Indications
No indication recorded.